Multivalent DNA-based vectors for DNA vaccine delivery.

Methods Mol Biol

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, One Leighton St, Unit 607, Cambridge, MA, 02141, USA,

Published: November 2014

DNA can be utilized as a generic delivery vector as well as a traditional biological material for DNA vaccination. Although the use of DNA as an antigen expression vector or a vaccine adjuvant has been intensively studied for several decades, the use of DNA molecules as a delivery carrier has not been explored until recently. This issue is probably due to the topological limitation of DNA in its natural linear or circular structure form. Multivalent DNA-based vector delivery platforms overcome this structural barrier and are particularly suited for DNA vaccine delivery because of their multifunctionality, monodispersity, anisotropicity, and bioconjugation ability with numerous functional moieties. In this chapter, we mainly describe the construction of multivalent DNA-based delivery vectors using DNA engineering methods. Specifically, the synthesis strategies for highly branched dendrimer-like DNA structures in general and methods for their application to DNA vaccine delivery are introduced.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-0410-5_11DOI Listing

Publication Analysis

Top Keywords

multivalent dna-based
12
dna vaccine
12
vaccine delivery
12
dna
10
vectors dna
8
delivery
7
dna-based vectors
4
vaccine
4
delivery dna
4
dna utilized
4

Similar Publications

Biomolecular condensates (BCs) are crucial membraneless organelles formed through the process of liquid-liquid phase separation (LLPS) involving proteins and nucleic acids. These LLPS processes are tightly linked with essential cellular activities. Stress granules (SGs), functioning as cytoplasmic BCs, play indispensable roles in maintaining cellular homeostasis and are implicated in diseases like cancers and neurodegenerative disorders.

View Article and Find Full Text PDF

Controllable multivalent LYTACs enhance targeted protein degradation.

Chem Commun (Camb)

January 2025

School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, 511442, P. R. China.

We present a versatile DNA-based LYTAC framework that allows control over the valency of chimeras and the distance between ligands through DNA self-assembly. By evaluating the degradation capabilities of LYTACs with 1, 3, and 9 valences, we confirm the broad applicability of the multivalent enhancement effect across different lysosome-targeting receptor-mediated degradation pathways. Our findings provide valuable insights into improving the degradation efficiency of LYTACs.

View Article and Find Full Text PDF
Article Synopsis
  • Using mesenchymal stem cells for skin injury treatment faces challenges like ensuring these cells can effectively integrate and maintain their healing properties.
  • DNA self-assembly techniques can be leveraged to create multifunctional structures on cell surfaces, boosting their therapeutic potential.
  • Engineered stem cells with DNA nanofiber decoration showed improved abilities to scavenge harmful reactive oxygen species, attach to damaged blood vessel cells, and promote new blood vessel formation, making them a promising option for healing wounds in a mouse model.
View Article and Find Full Text PDF

Lysosome-targeting chimera (LYTAC) shows great promise for protein-based therapeutics by targeted degradation of disease-associated membrane or extracellular proteins, yet its efficiency is constrained by the limited binding affinity between LYTAC reagents and designated proteins. Here, we established a programmable and multivalent LYTAC system by tandem assembly of DNA into a high-affinity protein degrader, a heterodimer aptamer nanostructure targeting both pathogenic membrane protein and lysosome-targeting receptor (insulin-like growth factor 2 receptor, IGF2R) with adjustable spatial distribution or organization pattern. The DNA-based multivalent LYTACs showed enhanced efficacy in removing immune-checkpoint protein programmable death-ligand 1 (PD-L1) and vascular endothelial growth factor receptor 2 (VEGFR2) in tumor cell membrane that respectively motivated a significant increase in T cell activity and a potent effect on cancer cell growth inhibition.

View Article and Find Full Text PDF

Assays that detect viral infections play a significant role in limiting the spread of diseases such as SARS-CoV-2. Here, we present Rolosense, a virus sensing platform that leverages the motion of 5 μm DNA-based motors on RNA fuel chips to transduce the presence of viruses. Motors and chips are modified with aptamers, which are designed for multivalent binding to viral targets and lead to stalling of motion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!